20
Aventis Pharma Deutschland Gmbh Frankfurt Am Main De, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
One of their significant offerings is Propyphenazone, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 1998-088 - Rev 00
This Chemical Type CEP, issued on December 07, 2004, remains in force until December 23, 2009, ensuring its reliability within the pharmaceutical industry.
Substance Number 636 associated with this CEP further emphasizes